Stoke Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Stoke Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q4 2024.
  • Stoke Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $4.35M, a 34.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $4.35M -$2.27M -34.3% Dec 31, 2024 10-K 2025-03-18
Q3 2024 $4.93M +$1.84M +59.8% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $5.5M +$1.85M +50.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $6.06M +$1.86M +44.2% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $6.61M +$1.86M +39.1% Dec 31, 2023 10-K 2025-03-18
Q3 2023 $3.08M -$2.21M -41.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.65M -$2.19M -37.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.2M -$361K -7.91% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.75M -$186K -3.77% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $5.3M -$31K -0.58% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.83M +$4.57M +364% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $4.56M +$3.72M +441% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.94M +$3.82M +343% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $5.33M +$3.95M +286% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.26M -$384K -23.4% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $844K -$1.06M -55.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.12M Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.38M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.64M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.9M Mar 31, 2020 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.